Kansas PKD Research and Translation Core Center

堪萨斯 PKD 研究与翻译核心中心

基本信息

批准号：
10059764
负责人：
JAMES P CALVET
金额：
$ 90.57万
依托单位：
UNIVERSITY OF KANSAS MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-07-15 至 2025-06-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10059764
关键词：
Autosomal Dominant Polycystic Kidney Basic Science Biochemistry Biocompatible Materials Biological Markers Biomedical Research Cancer Center Cell model Cell physiology Cellular biology Clinical Clinical Research Clinical Trials Clinical Trials Network Collaborations Communities Cyst Development Disease Drug Targeting Educational workshop Effectiveness Environment Foundations Goals Grant Growth Infrastructure Institutes Institution Interdisciplinary Study Kansas Kidney Medical center Methods Mission Pathogenesis Patient-Focused Outcomes Patients Polycystic Kidney Diseases Reagent Recording of previous events Research Research Methodology Research Personnel Research Support Resource Sharing Resources Rodent Model Series Services Site Technology Testing Translations Universities base biomarker discovery clinical development drug testing educational atmosphere improved innovation insight inter-institutional meetings multidisciplinary new technology novel therapeutic intervention novel therapeutics patient oriented programs recruit summer student symposium therapeutic target tool translational medicine

项目摘要

Project Summary – Overall The Kansas PKD Research and Translation Core Center (RTCC) is comprised of an Administrative Core and three innovative Biomedical Research Cores: Core 1: Biomarkers, Biomaterials, and Cellular Models; Core 2: Rodent Models & Drug Testing; and Core 3: Clinical Research. The Kansas RTCC also offers an Educational Enrichment Program and an internal Pilot Grant Program in partnership with the KU Cancer Center. The mission of the PKD Center is to promote PKD research by providing both innovative and essential reagents, biomaterials, and service to the national PKD research community for the advancement of our understanding of disease mechanisms, the discovery of biomarkers and therapeutic targets and the development of clinical trials to improve patient outcomes. The Specific Aims of the Kansas PKD RTCC are: Aim 1) To support PKD researchers nationally by developing innovative biomedical research cores. This will be accomplished by developing the expertise, reagents and resources required to bring the best new technologies to PKD research to meet the needs of the greater PKD research community; by leveraging existing institutional shared resources to expand our capability, efficiency, and effectiveness; and by developing tools to support clinical research and establish collaborations both regionally and nationally to develop a multi-institutional ADPKD clinical trials network. Aim 2) To develop a skilled, collaborative, multidisciplinary basic science and clinical PKD research investigator base. This will be accomplished by building on our broad multidisciplinary research base and continuing to recruit new investigators from outside the PKD field by offering an innovative pilot grant program that will attract new investigators to the field, and by providing new investigators, nationally, with research support for core services, new technologies, educational opportunities, and an open and collaborative research environment that will help them succeed. Aim 3) To enhance the PKD research environment with educational programs to support ongoing projects and to develop new research directions. The research environment will be enhanced through a seminar program, Summer Student Enrichment Program, PKD lab meetings, PKD methods workshops, Research Methods and Advanced Technologies Program, professional development seminar series, patient-oriented activities, and by participating in the consortium-wide annual symposium. Aim 4) To develop partnerships regionally and nationally and to build teams to serve as a resource for the greater PKD research community. Inter-institutional partnerships will provide local and national infrastructure support, new research technologies, increased numbers of patients involved in clinical trials, and research collaborators for the development of new research opportunities by attracting investigators from other fields into PKD research from collaborating sites within the PKD Research Consortium and with cooperating institutions nationwide, broadening opportunities beyond what any single institution can provide.

项目总结 – 总体堪萨斯 PKD 研究和翻译核心中心 (RTCC) 由行政核心和三个创新的生物医学研究核心：核心 1：生物标志物、生物材料和细胞模型核心 2：啮齿动物模型和药物测试；以及核心 3：临床研究堪萨斯 RTCC 还提供教育课程。与 KU 癌症中心合作开展丰富计划和内部试点资助计划。 PKD 中心的使命是通过提供创新和必要的试剂来促进 PKD 研究，生物材料，并为国家 PKD 研究界提供服务，以增进我们的理解疾病机制、生物标志物和治疗靶点的发现以及临床治疗的发展堪萨斯 PKD RTCC 的具体目标是：目标 1) 支持 PKD 通过开发创新的生物医学研究核心来实现全国研究人员的目标。开发将最好的新技术引入 PKD 研究所需的专业知识、试剂和资源通过利用现有的机构共享来满足更大的 PKD 研究界的需求；资源来扩展我们的能力、效率和有效性；并开发支持临床的工具；研究并在区域和国家范围内建立合作，以开发多机构 ADPKD 目标 2) 发展一个熟练的、协作的、多学科的基础科学和临床网络。这将通过我们广泛的多学科研究来实现。基地并通过提供创新试点补助金继续从 PKD 领域之外招募新的研究人员该计划将吸引新的调查人员到该领域，并通过在全国范围内为新的调查人员提供对核心服务、新技术、教育机会以及开放和协作的研究支持目标 3) 加强 PKD 研究环境。支持正在进行的项目并开发新的研究方向的教育计划。将通过研讨会计划、暑期学生拓展计划、PKD 实验室来改善环境会议、PKD 方法研讨会、研究方法和先进技术计划、专业发展研讨会系列、以患者为导向的活动以及参加联盟范围内的年度活动目标 4) 发展区域和国家伙伴关系并建立团队作为机构间合作伙伴关系将为更大的 PKD 研究界提供资源。基础设施支持、新的研究技术、参与临床试验的患者数量增加，以及研究合作者通过吸引其他研究人员来开发新的研究机会 PKD 研究联盟内的合作站点和合作机构将其领域纳入 PKD 研究全国范围内的机构，扩大了超出任何单一机构所能提供的机会。